Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Gastroenterology

  • News

    COVID-19 outcomes no worse in patients on TNF inhibitors or methotrexate

    September 16, 2020

    No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments during the COVID-19 pandemic, although more research is needed and shared decision making is warranted.

  • News

    Infectious COVID-19 can persist in gut for weeks

    September 14, 2020

    “We found active and prolonged SARS-CoV-2 infection in the stool of patients with COVID-19, even after recovery, suggesting that coronavirus could remain in the gut of asymptomatic carriers.”

  • 1
    News

    Mounting data support COVID-19 acute pancreatitis

    September 9, 2020

    “It has become increasingly clear that COVID-19 has systemic effects that also includes the gastrointestinal and pancreaticobiliary systems,” the investigators wrote.

  • 1
    News

    Tools emerging to predict liver failure in cirrhosis

    September 9, 2020

    Systemic inflammation, with high levels of proteins, is one of the mechanisms that leads to organ failure.

  • News

    Pandemic worsens disparities in GI and liver disease

    September 1, 2020

    Creative local solutions are needed to address screening and health care problems.

  • News

    COVID-19 at home: What does optimal care look like?

    August 31, 2020

    Most attention has focused on the sickest patients, leaving less severe cases to fall through the cracks.

  • 1
    News

    Famotidine associated with benefits in hospitalized COVID patients in another trial

    August 25, 2020

    “The mechanism of exactly how famotidine works has yet to be proven,” lead study author Jeffrey F. Mather said.

  • 1
    News

    Successful bowel preps linked with modifiable risk factors

    August 11, 2020

    What are modifiable risk factors associated with inadequate bowel preparation (IBP), and what is the association in hospitalized patients?

  • News

    Higher death rate seen in cancer patients with nosocomial COVID-19

    July 30, 2020

    All-cause mortality was higher in cancer patients with hospital-acquired COVID-19 than in those with community-acquired COVID-19.

  • 1
    News

    MIS-C is a serious immune-mediated response to COVID-19 infection

    July 28, 2020

    Multisystem inflammatory syndrome in children (MIS-C) is still a moving target because there is much still to learn about it.

Previous1 … 5 6 7 8 9 … 21Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences